a.fontaine
Submits third-party assay reports on material purchased directly. Based in Ibadan.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.05%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042768 | Semax | GGPeps | GGPE-2602-Y9952 | Janoshik | 2026-Q2 | 99.50 | 5.25 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042187 | TB-500 | JEEP | JEEP-2510-R9238 | Janoshik | 2026-Q1 | 99.47 | 4.61 | 94.9 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-018457 | Semaglutide | WWB | WWB-2507-V2845 | VendorInvestigate | 2025-Q4 | 99.05 | 4.88 | 98.8 | Buyer-sourced | 0 | PASS |
| AX-2024-004758 | Survodutide | Homopeptide | HOMO-2406-F5091 | Janoshik | 2024-Q4 | 99.39 | 4.83 | 98.4 | Buyer-sourced | 0 | PASS |
| AX-2024-004292 | Retatrutide | QSC | QSC-2411-C7111 | Kestrel | 2024-Q4 | 99.61 | 3.40 | 89.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005280 | Tirzepatide | BCH | BCH-2407-F4650 | Kestrel | 2024-Q4 | 98.39 | 5.02 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2024-004873 | Tirzepatide | ERP | ERP-2406-E9182 | PeptideMeter | 2024-Q3 | 98.01 | 4.74 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004723 | Retatrutide | Homopeptide | HOMO-2405-B3923 | PeptideMeter | 2024-Q3 | 97.93 | 5.54 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004450 | Hexarelin | GSP | GSP-2311-C2917 | Janoshik | 2024-Q1 | 99.02 | 5.03 | — | Buyer-sourced | 0 | PASS |